12:00 AM
 | 
Aug 03, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PLX-PAD: Phase I started

Pluristem began an open-label, German Phase I trial to evaluate intramuscular PLX-PAD in up to 15...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >